West Coast Financial’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-2,755
Closed -$844K 88
2015
Q4
$844K Buy
2,755
+637
+30% +$183K 0.35% 62
2015
Q3
$618K Buy
2,118
+1,548
+272% +$511K 0.28% 64
2015
Q2
$230K Buy
570
+20
+4% +$8.03K 0.1% 87
2015
Q1
$232K Sell
550
-50
-8% -$19.7K 0.11% 86
2014
Q4
$204K Buy
+600
New +$194K 0.11% 87

Other funds holding BIIB

West Coast Financial's BIIB Position: Q1 2016 in Review

West Coast Financial sold out of Biogen (BIIB) in Q1 2016, closing a stake of 2,755 shares — an estimated $844K sold.

West Coast Financial first reported a position in BIIB in Q4 2014 and held it in 5 quarters. The position peaked at $844K in Q4 2015. 948 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

  • West Coast Financial reported no remaining Biogen position as of Q1 2016 after selling out during the quarter.
  • West Coast Financial sold 2,755 Biogen shares in Q1 2016, an estimated $844K.
  • West Coast Financial first reported a position in Biogen in Q4 2014 and held it in 5 quarters.
  • West Coast Financial's Biogen position peaked at $844K in Q4 2015.
  • 948 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on West Coast Financial's 13F filing for Q1 2016, filed 2 May 2016.